New study tracks infection risks in patients with large leg implants
NCT ID NCT07544212
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is observing 200 patients who received a large leg implant (megaprosthesis) between 2020 and 2023. Researchers want to learn how many get infections, what puts them at risk, and how those infections turn out. The goal is to gather information, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand who is at risk for infections after lower-limb megaprosthesis surgery and how to prevent them.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test any new therapy. Results may not apply to all patients or hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2025
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All patients aged 14 years or older who underwent implantation of a lower-limb megaprosthesis at the participating Centers between January 1, 2020, and June 30, 2023, will be included.
- Ages
-
14 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 14 years * Implantation of a lower-limb megaprosthesis at one of the participating centers between January 1, 2020, and June 30, 2023 * At least 2 years of follow-up after megaprosthesis implantation * Signed informed consent Exclusion Criteria: * None
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lower limb megaprosthetis infection are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Irccs Azienda Ospedaliero-Universitaria Di Bologna
RECRUITINGBologna, BO, 40138, Italy